EUPRAXIA PHARMACEUTICALS INC.
EPRXNasdaqHealthcare · Pharmaceutical Preparations · A1 · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annualNo structured XBRL financials available (common for pre-2009 filers, foreign issuers, or companies that never reported as a US public company).
Clinical trials
ClinicalTrials.gov · ongoing · next readout firstInterventional studies led by this company. “Readout” is the trial's primary-completion date — an estimate the sponsor reports, not a guarantee.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 3.6M | 23.8 | +15.8% |
| Apr 30, 2026 | 3.1M | 17.8 | +19.8% |
| Apr 15, 2026 | 2.6M | 16.4 | +1.0% |
| Mar 31, 2026 | 2.5M | 10.5 | +1.6% |
| Mar 13, 2026 | 2.5M | 11.8 | +26.3% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Recent SEC filings
All filings ↗- 6-KFORM 6-KMay 29, 2026
- 6-KFORM 6-KMay 29, 2026
- 6-KFORM 6-KMay 28, 2026
- SCHEDULE 13G/AMay 12, 2026
- 6-KMay 12, 2026
- 6-KFORM 6-KMay 6, 2026
- 6-KFORM 6-KMay 5, 2026
- 6-KFORM 6-KMay 1, 2026
- 6-KFORM 6-KApr 22, 2026
- 6-KFORM 6-KApr 21, 2026
- 6-KFORM 6-KApr 15, 2026
- 6-KApr 15, 2026
- 6-KFORM 6-KMar 17, 2026
- SCHEDULE 13D/AMar 16, 2026
- 40-FMar 13, 2026
Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.